Superenhancer-transcription factor regulatory network in malignant tumors.

Liang, Yuan; Li, Linlin; Xin, Tian; Li, Binru; Zhang, Dalin

Liang, Yuan; Li, Linlin; Xin, Tian; Li, Binru; Zhang, Dalin.

Afiliação

Liang Y; Medical Oncology Department of Thoracic Cancer (2), Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang 110042, People's Republic of China.
Li L; Medical Oncology Department of Thoracic Cancer (2), Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang 110042, People's Republic of China.
Xin T; Medical Oncology Department of Thoracic Cancer (2), Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang 110042, People's Republic of China.
Li B; Medical Oncology Department of Thoracic Cancer (2), Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang 110042, People's Republic of China.
Zhang D; Department of Thyroid Surgery, The First Hospital of China Medical University, No. 155, Nanjing North Street, Shenyang 110001, Liaoning Province, People's Republic of China.

Open Med (Wars) ; 16(1): 1564-1582, 2021.

Article em En | MEDLINE | ID: mdl-34722892

Palavras-chave

ChIP-seq; RNA-seq; core regulatory circuitry; malignant tumors; super enhancers; superenhancertranscription factor regulatory network; transcription factors

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Open Med (Wars) Ano de publicação: 2021 Tipo de documento: Article País de publicação: Polônia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google